Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial
Éric Baudin(Institut Gustave Roussy), Anouk van Berkel(Unknown), Christina Pamporaki(University Hospital Carl Gustav Carus), Hanna Remde(University of Würzburg), Anne‐Paule Gimenez‐Roqueplo(Délégation Paris 5), Frédéric Castinetti(Inserm), Jérôme Bertherat(Centre National de la Recherche Scientifique), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), Timo Deutschbein(Klinikum Oldenburg), Olivier Chabre(Hôpital Albert Michallon), Antongiulio Faggiano(European Neuroendocrine Tumor Society), Felix Beuschlein(University of Zurich), Martín Reincke(LMU Klinikum), Judith Favier(Inserm), Magalie Haissaguerre(Université de Bordeaux), Bernard Goichot(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Stefanie Hahner(University of Würzburg), Ulrich Dischinger(Universitätsklinikum Würzburg), Carmina Teresa Fuß, Matthias Kroiß, Martin Faßnacht(University of Würzburg), Henri Timmers(Radboud University Nijmegen), Christian J. Strasburger(Humboldt-Universität zu Berlin), Rossella Libé(Hôpital Cochin), Alfredo Berruti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Christine Do Cao(Centre Hospitalier Universitaire de Lille), Matthieu Texier(Institut Gustave Roussy), Françoise Borson‐Chazot(Hospices Civils de Lyon), Christelle de la Fouchardière(Aix-Marseille Université), Stefania Zovato(Istituto Oncologico Veneto), Julien Hadoux(Université Paris-Saclay), Livia Lamartina(Institut Gustave Roussy), Michaela Haaf, Tina Kienitz, Laurence Amar(Unit of Functional and Adaptive Biology), M. Angokai(Inserm), Salma Moalla(Institut Gustave Roussy), Svenja Nölting(University of Zurich), Patricia Niccoli(Institut Paoli-Calmettes), Marcus Quinkler(Charité - Universitätsmedizin Berlin), Marie Attard(Institut Gustave Roussy), Delphine Drui, Katrin Zopf, Florina Luca(Hôpitaux Universitaires de Strasbourg), Sandrine Laboureau(Centre Hospitalier Universitaire d'Angers), Deborah Cosentini(University of Brescia)
Cited by 69
Related Papers
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|1.3k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k
The ratio of the nucleon structure functions F2N for iron and deuterium
|Physics Letters B|1983|1.1k
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
|Nature Reviews Clinical Oncology|2016|1.1k
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951